Phase II study of neoadjuvant durvalumab and tremelimumab in combination with gemcitabine and cisplatin in patients with intrahepatic cholangiocarcinoma that is borderline resectable or resectable with high risk for recurrence

被引：0

作者：

Sadagopan, Narayanan

Weinberg, Benjamin Adam

Noel, Marcus Smith

Mukherji, Reetu

Tesfaye, Anteneh A.

Marshall, John

Radkani, Pejman

Guerra, Juan F.

Nguyen, Brian M.

Fishbein, Thomas M.

He, Aiwu Ruth

机构：

[1] Univ Georgia, Lombardi Comprehens Canc Ctr, Med Ctr, Washington, DC USA

[2] Medstar Hlth, Washington, DC USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS4198

引用

页数：1